Deerfield Management Company, L.P. (Series C) Moderna, Inc. Transaction History
Deerfield Management Company, L.P. (Series C)
- $4.35 Billion
- Q2 2025
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Moderna, Inc. stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 1,000,000 shares of MRNA stock, worth $27.5 Million. This represents 0.63% of its overall portfolio holdings.
Number of Shares
1,000,000Holding current value
$27.5 Million% of portfolio
0.63%Shares
2 transactions
Others Institutions Holding MRNA
# of Institutions
862Shares Held
266MCall Options Held
28.5MPut Options Held
34.9M-
Vanguard Group Inc Valley Forge, PA41.7MShares$1.15 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$703 Million0.07% of portfolio
-
Baillie Gifford & CO22.1MShares$607 Million0.48% of portfolio
-
State Street Corp Boston, MA17.3MShares$475 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA8.88MShares$244 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $10.8B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...